Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00987662Phase 4Withdrawn
A Phase 4 trial of irbesartan in hypertension (HTN), sponsored by Aristotle University of Thessaloniki. Planned start Jan 2012; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00987662.